X-118759603-C-T
Variant names:
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001560.3(IL13RA1):c.676+1361C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.89 ( 30536 hom., 27718 hem., cov: 21)
Failed GnomAD Quality Control
Consequence
IL13RA1
NM_001560.3 intron
NM_001560.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.531
Publications
3 publications found
Genes affected
IL13RA1 (HGNC:5974): (interleukin 13 receptor subunit alpha 1) The protein encoded by this gene is a subunit of the interleukin 13 receptor. This subunit forms a receptor complex with IL4 receptor alpha, a subunit shared by IL13 and IL4 receptors. This subunit serves as a primary IL13-binding subunit of the IL13 receptor, and may also be a component of IL4 receptors. This protein has been shown to bind tyrosine kinase TYK2, and thus may mediate the signaling processes that lead to the activation of JAK1, STAT3 and STAT6 induced by IL13 and IL4. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Likely_benign. The variant received -4 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL13RA1 | ENST00000371666.8 | c.676+1361C>T | intron_variant | Intron 5 of 10 | 1 | NM_001560.3 | ENSP00000360730.3 | |||
IL13RA1 | ENST00000371642.1 | c.676+1361C>T | intron_variant | Intron 5 of 5 | 1 | ENSP00000360705.1 | ||||
IL13RA1 | ENST00000652600.1 | c.670+1361C>T | intron_variant | Intron 6 of 11 | ENSP00000498980.1 | |||||
IL13RA1 | ENST00000481868.1 | n.369+634C>T | intron_variant | Intron 3 of 5 | 3 |
Frequencies
GnomAD3 genomes AF: 0.887 AC: 96510AN: 108851Hom.: 30541 Cov.: 21 show subpopulations
GnomAD3 genomes
AF:
AC:
96510
AN:
108851
Hom.:
Cov.:
21
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Data not reliable, filtered out with message: InbreedingCoeff AF: 0.887 AC: 96553AN: 108907Hom.: 30536 Cov.: 21 AF XY: 0.890 AC XY: 27718AN XY: 31161 show subpopulations
GnomAD4 genome
Data not reliable, filtered out with message: InbreedingCoeff
AF:
AC:
96553
AN:
108907
Hom.:
Cov.:
21
AF XY:
AC XY:
27718
AN XY:
31161
show subpopulations
African (AFR)
AF:
AC:
27292
AN:
29860
American (AMR)
AF:
AC:
9334
AN:
10138
Ashkenazi Jewish (ASJ)
AF:
AC:
2493
AN:
2629
East Asian (EAS)
AF:
AC:
3467
AN:
3469
South Asian (SAS)
AF:
AC:
2334
AN:
2422
European-Finnish (FIN)
AF:
AC:
4697
AN:
5540
Middle Eastern (MID)
AF:
AC:
200
AN:
213
European-Non Finnish (NFE)
AF:
AC:
44843
AN:
52478
Other (OTH)
AF:
AC:
1337
AN:
1488
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
399
799
1198
1598
1997
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
774
1548
2322
3096
3870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.